We are live on ! Find out more
CVS icon

CVS Health

1,483 hedge funds and large institutions have $97.6B invested in CVS Health in 2015 Q2 according to their latest regulatory filings, with 89 funds opening new positions, 605 increasing their positions, 605 reducing their positions, and 48 closing their positions.

New
Increased
Maintained
Reduced
Closed

85% more first-time investments, than exits

New positions opened: 89 | Existing positions closed: 48

4% more funds holding in top 10

Funds holding in top 10: 218227 (+9)

2% more funds holding

Funds holding: 1,4601,483 (+23)

7% more call options, than puts

Call options by funds: $464M | Put options by funds: $434M

1% more capital invested

Capital invested by funds: $96.9B → $97.6B (+$674M)

0% more repeat investments, than reductions

Existing positions increased: 605 | Existing positions reduced: 605

0.77% less ownership

Funds ownership: 83.7%82.93% (-0.77%)

Holders
1,483
Holders Change
+23
Holders Change %
+1.58%
% of All Funds
39.94%
Holding in Top 10
227
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+4.13%
% of All Funds
6.11%
New
89
Increased
605
Reduced
605
Closed
48
Calls
$464M
Puts
$434M
Net Calls
+$29.7M
Net Calls Change
-$54.4M
Name Holding Trade Value Shares
Change
Change in
Stake
Pzena Investment Management
201
Pzena Investment Management
New York
$55.3M +$10.2K +100 +0%
RCM
202
Riverhead Capital Management
Delaware
$54.7M -$433K -4,237 -0.8%
FIM
203
Foresters Investment Management
New York
$53.2M +$1.49M +14,600 +3%
CCMH
204
Cornerstone Capital Management Holdings
New York
$53M +$5.78M +56,612 +13%
PI
205
PineBridge Investments
New York
$51.8M +$2.64M +25,845 +6%
SAM
206
Sawgrass Asset Management
Florida
$51.7M +$832K +8,146 +2%
SAM
207
Sentinel Asset Management
Vermont
$49.5M -$2.55M -25,000 -5%
WBC
208
Westpac Banking Corp
Australia
$48.9M +$942K +9,218 +2%
Voloridge Investment Management
209
Voloridge Investment Management
Florida
$48.3M +$36.8M +360,262 +358%
FWCM
210
Ferguson Wellman Capital Management
Oregon
$48M +$837K +8,195 +2%
TSU
211
TD Securities (USA)
New York
$47.9M +$5.39M +52,735 +13%
EA
212
Euclid Advisors
Connecticut
$47.6M +$31.7M +310,058 +216%
IGIM
213
I.G. Investment Management
Manitoba, Canada
$47.4M +$4.62M +45,263 +11%
WF
214
Welch & Forbes
Massachusetts
$46.8M +$510K +4,991 +1%
HI
215
Honeywell International
North Carolina
$46.5M -$11.3M -110,500 -20%
National Pension Service
216
National Pension Service
South Korea
$46.2M +$6.36M +62,205 +16%
AL
217
AJO LP
Pennsylvania
$45.9M +$9.66M +94,500 +28%
SC
218
Stralem & Co
New York
$45.8M -$10.1M -98,952 -18%
RIG
219
Roosevelt Investment Group
New York
$44.9M -$7.66M -75,011 -15%
HEIP
220
Hudson Edge Investment Partners
New Jersey
$44.4M -$958K -9,377 -2%
TPSF
221
Texas Permanent School Fund
Texas
$43.1M -$1.07M -10,471 -2%
Nisa Investment Advisors
222
Nisa Investment Advisors
Missouri
$43M -$5.19M -50,774 -11%
DekaBank Deutsche Girozentrale
223
DekaBank Deutsche Girozentrale
Germany
$42.9M +$9.68M +94,750 +30%
FMW
224
Farr Miller & Washington
District of Columbia
$42.2M +$209K +2,049 +0.5%
OTPPB
225
Ontario Teachers' Pension Plan Board
Ontario, Canada
$41.3M +$18.6M +181,907 +86%

CVS Hedge Fund Activity: Q2 2015 in Review

1,483 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q2 2015, worth a combined $97.6B — up 0.7% from $96.9B a quarter earlier.

Buyers outnumbered sellers: 89 funds opened new CVS positions and 48 closed out — a net gain of 41 holders — while 605 added to existing stakes and 605 trimmed.

The largest buyer was Ameriprise, adding an estimated $501M. The largest seller was JP Morgan Chase, cutting an estimated $779M.

  • 1,483 institutional investors held CVS Health (CVS) as of Q2 2015, up from 1,460 in Q1 2015.
  • Funds reported $97.6B of CVS Health stock for Q2 2015, up 0.7% quarter-over-quarter.
  • 89 funds opened new CVS Health positions in Q2 2015 and 48 closed out, a net change of +41 holders.
  • The largest CVS Health buyer in Q2 2015 was Ameriprise, an estimated $501M added.
  • The largest CVS Health seller in Q2 2015 was JP Morgan Chase, an estimated $779M sold.

Based on aggregated 13F filings for Q2 2015.